Drug-coated Balloon Versus Conventional Balloon Angioplasty of Hemodialysis Arteriovenous Fistula or Graft: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2020 Apr 15

PMID 32287283

Citations 15

Authors

Min-Tsun Liao

Meng-Kan Chen

Mu-Yang Hsieh

Nai-Lun Yeh

Kuo-Liong Chien

Chih-Ching Lin

Chih-Cheng Wu

Wei-Chu Chie

Affiliations

Soon will be listed here.

Abstract

Background: Restenosis remains a significant problem in endovascular therapy for hemodialysis vascular access. Drug-coated balloon (DCB) angioplasty decreases restenosis in peripheral and coronary artery diseases. The aim of this systematic review and meta-analysis is to assess the patency outcomes following DCB angioplasty, as compared to conventional balloon (CB) angioplasty for the stenosis of hemodialysis vascular access.

Methods: A comprehensive search in the MEDLINE, EMBASE, and CENTRAL databases was conducted in order to identify eligible randomized controlled trials evaluating DCB angioplasty for hemodialysis vascular access dysfunction. The primary endpoint was the 6-month target lesion primary patency and the secondary endpoints were 12-month target lesion primary patency and procedure-related complications. Risk ratios (RR) were pooled and relevant subgroups were analyzed separately.

Results: Eleven randomized controlled trials comprised of 487 patients treated with DCB angioplasty and 489 patients treated with CB angioplasty were included. There were no significant differences in the target lesion primary patency at 6 months [RR, 0.75; 95% confidence interval (CI), 0.56, 1.01; p = 0.06] and at 12 months (RR 0.89; 95% CI, 0.79, 1.00; p = 0.06). The absence of benefit for the DCB group remained, even in the arteriovenous fistula subgroup or the subgroup of studies excluding central vein stenosis. The risk of procedure-related complication did not differ between the two groups (RR 1.00; 95% CI 0.98, 1.02; p = 0.95).

Conclusion: DCB angioplasty did not demonstrate significant patency benefit for the treatment of hemodialysis vascular access dysfunction. Wide variations in patency outcomes across studies were noted. Further studies focusing on specific types of access or lesions are warranted to clarify the value of DCB for hemodialysis vascular access. (PROSPERO Number CRD42019119938).

Citing Articles

Efficacy of drug-coated balloon versus uncoated balloon for dysfunctional dialysis access: a systematic review and meta-analysis.

Elahi A, Qamar M, Khan F, Babar R, Zahid M, Ahmad M Clin Exp Nephrol. 2025; .

PMID: 39992495 DOI: 10.1007/s10157-025-02642-7.

Classifications of haemodialysis vascular access stenosis: a scoping review.

Lawrie K, ONeill S, Malik J, Janousek L, Corr M, Maly S BMJ Open. 2025; 15(1):e088045.

PMID: 39819957 PMC: 11751806. DOI: 10.1136/bmjopen-2024-088045.

Cephalic arch stenosis: an analysis of outcome by type of first intervention.

Pisano U, Stevenson K, Kasthuri R, Kingsmore D CVIR Endovasc. 2024; 7(1):13.

PMID: 38240913 PMC: 10798936. DOI: 10.1186/s42155-023-00424-4.

A Prospective Multicenter Randomized Controlled Trial for Comparing Drug-Coated and Conventional Balloon Angioplasty in Venous Anastomotic Stenosis of Hemodialysis Arteriovenous Grafts.

Goo D, Kim Y, Park S, Cheon H, Won Y, Yang S Cardiovasc Intervent Radiol. 2023; 47(1):36-44.

PMID: 38010504 DOI: 10.1007/s00270-023-03536-5.

Comparison of drug-coated balloon angioplasty versus common balloon angioplasty for arteriovenous fistula stenosis: A systematic review and meta-analysis.

Zhang Y, Yuan F, Hu X, Wang Q, Zou Z, Li Z Clin Cardiol. 2023; 46(8):877-885.

PMID: 37417371 PMC: 10436783. DOI: 10.1002/clc.24078.

References

Deeks J, Macaskill P, Irwig L . The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005; 58(9):882-93. DOI: 10.1016/j.jclinepi.2005.01.016. View

Lucev J, Breznik S, Dinevski D, Ekart R, Rupreht M . Endovascular Treatment of Haemodialysis Arteriovenous Fistula with Drug-Coated Balloon Angioplasty: A Single-Centre Study. Cardiovasc Intervent Radiol. 2018; 41(6):882-889. DOI: 10.1007/s00270-018-1942-z. View

Kennedy S, Mafeld S, Baerlocher M, Jaberi A, Rajan D . Drug-Coated Balloon Angioplasty in Hemodialysis Circuits: A Systematic Review and Meta-Analysis. J Vasc Interv Radiol. 2019; 30(4):483-494.e1. DOI: 10.1016/j.jvir.2019.01.012. View

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009; 151(4):W65-94. DOI: 10.7326/0003-4819-151-4-200908180-00136. View

Wee I, Yap H, Hsien Tsung L, Lee Qingwei S, Tan C, Tang T . A systematic review and meta-analysis of drug-coated balloon versus conventional balloon angioplasty for dialysis access stenosis. J Vasc Surg. 2019; 70(3):970-979.e3. DOI: 10.1016/j.jvs.2019.01.082. View

Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U . Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006; 355(20):2113-24. DOI: 10.1056/NEJMoa061254. View

Clark T, Hirsch D, Jindal K, Veugelers P, LeBlanc J . Outcome and prognostic factors of restenosis after percutaneous treatment of native hemodialysis fistulas. J Vasc Interv Radiol. 2002; 13(1):51-9. DOI: 10.1016/s1051-0443(07)60009-8. View

Kitrou P, Papadimatos P, Spiliopoulos S, Katsanos K, Christeas N, Brountzos E . Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Dialysis Access: Results from a Randomized Controlled Trial. J Vasc Interv Radiol. 2017; 28(6):811-817. DOI: 10.1016/j.jvir.2017.03.007. View

Liao M, Lee C, Lin T, Jong C, Chen T, Lin L . A randomized controlled trial of drug-coated balloon angioplasty in venous anastomotic stenosis of dialysis arteriovenous grafts. J Vasc Surg. 2019; 71(6):1994-2003. DOI: 10.1016/j.jvs.2019.07.090. View

10.

Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. PMC: 3196245. DOI: 10.1136/bmj.d5928. View

11.

Maleux G, Vander Mijnsbrugge W, Henroteaux D, Laenen A, Cornelissen S, Claes K . Multicenter, Randomized Trial of Conventional Balloon Angioplasty versus Paclitaxel-Coated Balloon Angioplasty for the Treatment of Dysfunctioning Autologous Dialysis Fistulae. J Vasc Interv Radiol. 2018; 29(4):470-475.e3. DOI: 10.1016/j.jvir.2017.10.023. View

12.

Moreno-Sanchez T, Moreno-Ramirez M, Machancoses F, Pardo-Moreno P, Navarro-Vergara P, Garcia-Revillo J . Efficacy of Paclitaxel Balloon for Hemodialysis Stenosis Fistulae After One Year Compared to High-Pressure Balloons: A Controlled, Multicenter, Randomized Trial. Cardiovasc Intervent Radiol. 2019; 43(3):382-390. DOI: 10.1007/s00270-019-02372-w. View

13.

Kitrou P, Spiliopoulos S, Katsanos K, Papachristou E, Siablis D, Karnabatidis D . Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial. J Vasc Interv Radiol. 2014; 26(3):348-54. DOI: 10.1016/j.jvir.2014.11.003. View

14.

Irani F, Teo T, Tay K, Yin W, Win H, Gogna A . Hemodialysis Arteriovenous Fistula and Graft Stenoses: Randomized Trial Comparing Drug-eluting Balloon Angioplasty with Conventional Angioplasty. Radiology. 2018; 289(1):238-247. DOI: 10.1148/radiol.2018170806. View

15.

Lai C, Fang H, Tseng C, Liu C, Mar G . Percutaneous angioplasty using a paclitaxel-coated balloon improves target lesion restenosis on inflow lesions of autogenous radiocephalic fistulas: a pilot study. J Vasc Interv Radiol. 2014; 25(4):535-41. DOI: 10.1016/j.jvir.2013.12.014. View

16.

Beathard G, Lok C, Glickman M, Al-Jaishi A, Bednarski D, Cull D . Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access. Clin J Am Soc Nephrol. 2017; 13(3):501-512. PMC: 5967683. DOI: 10.2215/CJN.11531116. View

17.

Bjorkman P, Weselius E, Kokkonen T, Rauta V, Alback A, Venermo M . Drug-Coated Versus Plain Balloon Angioplasty In Arteriovenous Fistulas: A Randomized, Controlled Study With 1-Year Follow-Up (The Drecorest Ii-Study). Scand J Surg. 2018; 108(1):61-66. DOI: 10.1177/1457496918798206. View

18.

Cildag M, Koseoglu O, Akdam H, Yenicerioglu Y . The primary patency of drug-eluting balloon versus conventional balloon angioplasty in hemodialysis patients with arteriovenous fistula stenoses. Jpn J Radiol. 2016; 34(10):700-704. DOI: 10.1007/s11604-016-0577-8. View

19.

Trerotola S, Saad T, Roy-Chaudhury P . The Lutonix AV Randomized Trial of Paclitaxel-Coated Balloons in Arteriovenous Fistula Stenosis: 2-Year Results and Subgroup Analysis. J Vasc Interv Radiol. 2019; 31(1):1-14.e5. DOI: 10.1016/j.jvir.2019.08.035. View

20.

Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwalder U, Beregi J . Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008; 358(7):689-99. DOI: 10.1056/NEJMoa0706356. View